BiotechTube
Diagenics

Diagenics

Copenhagen, Europe - Other· Est.
diagenics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Diagenics is a diagnostics company leveraging a proprietary biomarker platform to create rapid tests for emergency and critical care settings. Its product portfolio targets large markets in gynecology (preeclampsia), neurology (stroke), and cardiology (heart attack), with an additional commercial line in virology (COVID-19 antigen tests). Founded in 2005 and headquartered in Luxembourg with operational offices in Germany, the company positions itself as a pioneer in improving diagnostic speed and accuracy to influence patient outcomes.

GynecologyNeurologyCardiologyVirology

Technology Platform

Proprietary biomarker platform for rapid, point-of-care diagnostic tests, utilizing lateral flow immunoassay principles for early detection of acute conditions.

Opportunities

Large addressable markets in acute care (stroke, heart attack, preeclampsia) with a need for faster, more accurate point-of-care diagnostics.
The proprietary biomarker platform allows for expansion into multiple high-value indications.
Existing commercial infrastructure for COVID-19 tests provides a revenue base and pathway for launching future products.

Risk Factors

Faces significant regulatory and reimbursement challenges for novel biomarker adoption.
Competes against large, established diagnostics companies with deep R&D and sales resources.
Clinical utility and superiority over existing standards of care must be conclusively proven to achieve market penetration.

Competitive Landscape

Operates in competitive segments dominated by global IVD leaders like Roche, Abbott, Siemens Healthineers, and Becton Dickinson. Also competes with specialized point-of-care companies and other startups developing novel biomarkers for acute care. Differentiation hinges on the performance and clinical validation of its undisclosed proprietary biomarker.

More companies in Diagnostics & Precision Medicine →More companies in Europe - Other →